ALFA VALVOLE acquired by INTERPUMP GROUP

Spectris has acquired SciAps. SciAps will be integrated into Malvern Panalytical (Spectris Scientific division). The acquisition accelerates Spectris's digital strategy by moving analysis "closer to the sample" (from lab to field). SciAps' handheld XRF and LIBS devices complement Malvern Panalytical's benchtop range, creating a comprehensive suite for customers in mining, recycling, and batteries.

Thermo Fisher Scientific has finalized the acquisition of Olink Holding AB, an operation designed to fundamentally strengthen the group's capabilities in the high-growth proteomics market. The strategic rationale for this transaction centers on a "platform-complementarity" play, merging the target's industry-leading protein analysis technology with the group’s established leadership in mass spectrometry and life sciences instrumentation. This fusion effectively creates a specialized powerhouse in the protein biomarker discovery arena, providing the organization with the necessary technical operational depth to address the increasing demand for precision medicine solutions. This operation allows the group to execute a definitive structural expansion into the high-throughput proteomics sector, specifically targeting the installed base of sequencing systems. By incorporating the target's proprietary PEA technology, the organization can now provide a more robust and integrated solution set for researchers looking to accelerate scientific breakthroughs. The maneuver optimizes the group's financial profile through the realization of significant revenue and cost synergies while leveraging its global commercial machine to drive international market penetration. Ultimately, the partnership solidifies the group’s standing as a primary enabler of proteomic innovation, bridging the gap between sophisticated laboratory-scale diagnostics and industrialized pharmaceutical research standards.

The acquisition of The L.S. Starrett Company by MiddleGround Capital represents a significant take-private transaction in the industrial tools sector, concluding the company's 144-year history as a publicly-traded entity. Strategically, this move allows Starrett to transition from the quarterly pressures of the public markets to a private environment where it can focus on long-term operational flexibility and strategic capital deployment. The rationale for the investment centers on MiddleGround's intent to amplify Starrett's iconic brand status by scaling its geographic reach and diversifying its robust range of metrology and cutting tool offerings. The partnership aims to capitalize on key industrial trends, including the resurgence of advanced manufacturing and the reshoring of critical production to North America. Following the shareholder approval and delisting from the New York Stock Exchange, the company will benefit from MiddleGround’s deep operational expertise and financial backing to professionalize its global manufacturing footprint.

Ambienta, one of Europe�s largest asset managers entirely focused on environmental sustainability, has announced the acquisition of a majority stake in Babcock Wanson Group. The firm is acquiring the stake alongside Kartesia, the current shareholder who is reinvesting a portion of its proceeds, and the company's management team. The transaction, announced in June 2024, is expected to close in Q3 2024.

Triton acquired the Trench business from Siemens Energy. The deal allows Siemens Energy to sharpen its portfolio while giving Trench the independence to invest in capacity expansion to meet the booming demand for grid infrastructure. Triton supported the carve-out and setup of standalone functions.

Astorg has preempted the sale process of Steliau Technology to become its new majority shareholder, marking the company’s fourth LBO. Orchestrated by DDA & Cie, The transaction was financed via an unitranche debt structure, following the model of the previous LBO cycle. This strategic partnership is strictly engineered to accelerate Steliau's pan-European consolidation strategy, specifically targeting new entries into the German, UK, and Scandinavian markets to capitalize on the highly fragmented €3Bn European electronic distribution sector.

Ingersoll Rand has successfully finalized a definitive agreement to acquire 100% of ILC Dover from New Mountain Capital, marking a transformative expansion into the life sciences sector. This strategic transaction establishes a dedicated life sciences platform within the group’s Precision and Science Technologies (P&ST) segment, consolidating the target’s expertise with the group’s existing brands to create a $700 million revenue vertical. The strategic rationale for the move centers on the convergence of the target’s innovative single-use biopharma solutions with the group’s established liquid handling and positive displacement pump technologies. By incorporating the target’s established direct channels and deep connectivity with over 1,000 biopharma and medical device customers, the organization significantly increases its addressable market in highly fragmented growth segments. The partnership focuses on leveraging the group’s demand generation capabilities to drive cross-selling opportunities across its broader industrial product lines, such as specialized compressors and vacuum solutions. This integration reinforces the group’s position as a primary enabler of advanced medical therapy production and pharmaceutical innovation, providing the operational depth required to achieve high-single-digit returns on invested capital through standardized industrial excellence.

IK Partners, through its IK X Fund, has entered into exclusive negotiations to acquire a majority stake in Eurofeu, a leading player in the French fire protection market. IK is acquiring the stake from CAPZA and the management team, both of whom will be reinvesting to support the Group's next development phase.

The merger between Standard BioTools and SomaLogic creates a diversified and scaled leader in the life sciences tools industry. The strategic rationale for this transaction centers on a "multi-omic integration" play, merging the target's technical operational depth in proteomics with the group's established mass cytometry and microfluidics platforms. This fusion effectively creates a specialized powerhouse capable of delivering clinical research insights with high throughput and data quality across approximately 50 countries. This operation allows the group to execute a definitive structural expansion of its commercial reach, leveraging substantial cross-selling opportunities between the target’s biopharmaceutical research footprint and the group’s academic research settings. By incorporating the target's innovative proteomic tools, the organization can now provide a more robust and integrated solution set for translational and clinical research. The maneuver optimizes the group's financial profile through the realization of significant cost synergies while utilizing a formidable capital structure to self-fund future growth initiatives. Ultimately, the partnership solidifies the group’s standing as a primary enabler of multi-omic innovation, bridging the gap between sophisticated laboratory-scale research and industrialized pharmaceutical development standards.

The successful acquisition of Advanced Micro Instruments (AMI) by Enpro Inc. marks a decisive tactical expansion of the group’s capabilities within the compositional analysis market. This transaction facilitates the integration of Advanced Micro Instruments' proprietary sensing technologies into Enpro Inc.’s Sealing Technologies segment, creating a broader portfolio of solutions for safeguarding critical environments. The strategic rationale hinges on the fusion of Advanced Micro Instruments’ gas analysis expertise with Enpro Inc.’s established reach in the midstream energy and industrial processing sectors. By incorporating Advanced Micro Instruments, Enpro Inc. reinforces its ability to address the increasing regulatory and environmental demand for methane emission reduction and biogas monitoring. The partnership is designed to leverage Enpro Inc.’s industrialized operating model to accelerate the scaling of Advanced Micro Instruments’ sensor portfolio across global markets. This integration facilitates the creation of a more robust technical platform, providing the strategic depth required to navigate the clean energy transition. The move solidifies Enpro Inc.’s standing as a primary provider of mission-critical instrumentation and environmental protection hardware.